Insider buying · SEC Form 4

Insider Buying — Nov 18, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

6insider buys
$3.29Mbought in total
6companies
1by CEOs, CFOs and other chiefs
DKNGlargest: $1.00M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
DKNGDraftKings Inc.Matthew KalishDirector$1.00M55,000$18.22AddedNov 17, 2026
Form 4 ↗
Weighted avg $18.22 (range $18.01–$18.44); co-founder conviction buy near multi-month lows; now $18.00 (-1.2% vs buy)
KTTAPasithea Therapeutics Corp.Coastlands Capital LP10% Owner$806K1,667,514$0.48AddedNov 17, 2026
Form 4 ↗
3-tranche accumulation Nov 13–17 at blended avg $0.483; now $0.434 (-10.1%); same cluster buyer also active in BOLT same day
TSMTaiwan Semiconductor Manufacturing Company Ltd.Burns Ursula MNon-Executive Director$500K1,375$363.67AddedNov 18, 2026
Form 4 ↗
Unusual Form 4 for foreign private issuer director; bought at $363.67; now $359.69 (-1.1%); bullish semi signal
PLBYPlayboy Inc.Docler Holding S.a r.l.Director$368K283,000$1.30AddedNov 17, 2026
~$368K aggregator-reported buy; share count estimated; SEC URL not confirmed; now $1.26
BOLTBolt Biotherapeutics Inc.Coastlands Capital LP10% Owner$310K54,867$5.65AddedNov 17, 2026
~$310K aggregator-reported buy; same 10% owner as KTTA cluster; SEC URL not confirmed; now $5.65
SSIISS Innovations International Inc.Sudhir SrivastavaChairman/CEO$300K225,564$1.33AddedNov 17, 2026
~$300K aggregator-reported CEO/founder buy in surgical robotics micro-cap; SEC URL not confirmed; now $1.33

AIThe day in insider buying

SEC Form 4 Insider Scan — November 18, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 6 qualifying buys (≥ $250K, transaction type P) totalling ~$3.3M.

Headline filings

  • DKNG — Matthew Kalish (Director) bought 55,000 shares ≈ $1.0M at $18.22 avg; now $18.00 (-1.2% since buy). (filing)
  • KTTA — Coastlands Capital LP (10% Owner) bought 1,667,514 shares ≈ $806K at $0.483 blended avg (3 tranches Nov 13–17); now $0.434 (-10.1% since buy). (filing)
  • TSM — Burns Ursula M (Non-Executive Director) bought 1,375 shares ≈ $500K at $363.67; now $359.69 (-1.1% since buy). (filing)
  • PLBY — Docler Holding S.a r.l. (Director) bought ≈ $368K; now $1.26. (Aggregator-sourced; SEC URL pending verification.)
  • BOLT — Coastlands Capital LP (10% Owner) bought ≈ $310K; now $5.65. (Aggregator-sourced; SEC URL pending verification.)
  • SSII — Sudhir Srivastava (Chairman/CEO) bought ≈ $300K; now $1.33. (Aggregator-sourced; SEC URL pending verification.)

Notes

Sector themes: Consumer discretionary (DKNG gaming, PLBY lifestyle), biotech/therapeutics (KTTA Pasithea, BOLT Biotherapeutics), technology (TSM semiconductors, SSII surgical robotics).

Cluster buying: Coastlands Capital LP appears in both KTTA and BOLT — same 10% owner accumulating two small-cap biotech names on the same day. Concentrated 10% owner cluster activity is a high-conviction signal.

DraftKings conviction buy: Matthew Kalish is a DraftKings co-founder; a $1M open-market buy near multi-month lows signals deep insider conviction. The $18.22 avg buy is close to 52-week support in the $17–$18 range.

TSM unusual: Foreign private issuers rarely generate Form 4 activity. Director Burns buying 1,375 ADRs at $363.67 is notable; adds to bullish semiconductor supply-chain sentiment heading into year-end.

KTTA note: The $806K total spans Nov 13–17 across three P-coded purchase tranches, all filed on 2026-11-17. Only the Nov 17 tranche ($411K) falls strictly within 24 hours of the scan window, but the full filing is captured here per standard aggregation practice.

Most-bought stocks, last 30 days

  • CRBG $80.4M · 9 buys, 2 insidersCorebridge Financial, Inc.
  • LRN $57.1M · 5 buys, 3 insidersStride, Inc.
  • LYCA $37.7M · 1 buyLycia Therapeutics, Inc.
  • COUR $31.4M · 1 buyCoursera, Inc.
  • MSM $29.0M · 1 buyMSC Industrial Direct Co., Inc.
  • SIRI $26.9M · 1 buySirius XM Holdings Inc.
  • LYEL $25.0M · 1 buyLyell Immunopharma, Inc.
  • GPI $24.2M · 1 buyGroup 1 Automotive Inc.
  • FUN $22.9M · 3 buys, 2 insidersSix Flags Entertainment Corp
  • DOLE $21.5M · 2 buys, 2 insidersDole plc
  • SRRK $12.0M · 1 buyScholar Rock Holding Corp
  • IAM $11.5M · 1 buyIambic Therapeutics, Inc.
  • GLXY $9.86M · 1 buyGalaxy Digital Inc.
  • INTC $9.71M · 1 buyIntel Corporation
  • MP $6.12M · 4 buys, 4 insidersMP Materials Corp
  • TXO $5.29M · 3 buys, 2 insidersTXO Partners LP
  • LILAK $4.98M · 1 buyLiberty Latin America Ltd
  • BPRE $4.65M · 2 buysBluerock Private Real Estate Fund
  • ETRA $4.35M · 2 buys, 2 insidersElectra Therapeutics, Inc.
  • GOLD $3.93M · 1 buyGold.com, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.